Sponsored Early-Career Research Grant

The Sponsored Early-Career Research Grant (ECR), supported by Acerta Pharma, a member of the AstraZeneca Group, will provide funding to promising investigators early in their career to encourage and promote quality, basic, and pre-clinical translational lab-based research, although clinical research may also be considered, in hematology/oncology among HOPA members. This Grant has been awarded, and the grant is closed.

Research Fund Award

The Research Fund Award is intended to support a hematology/oncology pharmacy practice research project with subsequent publication that aligns closely with the HOPA strategic plan to demonstrate the value of hematology/ oncology pharmacy practice. Pharmacy practice is broadly defined to include areas of research such as: clinical or patient outcomes, surveys, patient safety, standards validation, and basic/translational science applications. Multiple institutions may be involved in the project, and a project with co-PIs are allowed. A subsequent publication resulting from the research project is expected within a year of the study completion.

A total of $100,000 is available to be awarded to up to three grants through a competitive peer-review process described below. HOPA aims to fund at least one practice-based and one basic/translational study.

Please submit a full proposal (no LOI submissions this year) to HOPA (This email address is being protected from spambots. You need JavaScript enabled to view it.) by 11:59PM CST on October 29th, 2021. For more information, please click here.